The Clinical Research of Anti-CD20 CAR-T Cells in Patients With Refractory or Relapsed B Lymphocyte Lymphoma

Clinical trial NCT03576807 · UNKNOWN

Trial details

NCT number: NCT03576807
Sponsor: Xin Wang
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory B-cell Lymphomas

Start date: 2018-04-04
Primary completion: 2019-04-03
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.